Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Bajaj Healthcare Reg Gr
as of 22 Jul 2026, 18:55 PM
Invested Amount
Est. Return
Total Value
rated by Value Research
Your principal will be at Very High Risk
Absolute Returns
CAGR
Equity / Debt / Cash Split
Equity
96.15%
Debt
0.16%
Cash
3.68%
Others
0.01%
Equity sector allocation
Basic Materials
4.2%
Consumer Defensive
2.82%
Financial Services
1%
Healthcare
87.8%
Industrials
0.32%
Others
3.86%
Asset Management Company

Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
29.75%
63.78%
3Y Returns
+63.78%

DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
29.75%
63.78%
3Y Returns
+45.98%

DSP Wld Gld Mng Ovrs Eq Omni FoF IDCW-R
Equity
Min. Investment
₹100
Category Returns
29.75%
63.78%
3Y Returns
+45.89%
Investment Objective of the Scheme
Key Features of The Fund
5-year return
-
Fund Manager
Siddharth Chaudhary
Risk Profile
Very High Risk
Expense Ratio
2.09%
Fund Size
₹354.03 Cr
Bajaj Healthcare Reg Gr is currently priced at ₹11.28, as of 22 Jul 2026, 18:55 PM. The fund has recorded a change of ₹0.06 (0.49%), indicating its recent movement in the market.
Tracking NAV trends helps investors understand short-term price movement, while long-term performance gives a better picture of wealth creation potential.
Bajaj Healthcare Reg Gr is an open-ended mutual fund that invests based on its stated objective and benchmark.
Key details:
Asset Size: ₹354.03 Cr
Expense Ratio: 2.09%
Cash Holding: 3.68%
Plan Type: Growth
Benchmark: BSE Healthcare TR INR
Launch Date: 2024-12-27
Exit Load: 1.00
These factors help investors evaluate cost, scale, and fund positioning before making an investment decision.
Bajaj Healthcare Reg Gr has delivered returns across multiple timeframes, reflecting its ability to perform across different market conditions.
Returns:
1 Month: 6.15%
3 Months: 17.60%
6 Months: 23.11%
1 Year: 14.25%
3 Years: -
5 Years: -
Short-term returns indicate recent momentum, while long-term returns show consistency and wealth creation ability.
Understanding risk is important before investing. Bajaj Healthcare Reg Gr falls under: For investors in the 20–40 age group, selecting a fund with the right risk level is important based on financial goals, investment horizon, and comfort with market movements.
Risk Level: Very High Risk
The riskometer helps investors understand how stable or volatile the fund can be based on its investment strategy and asset allocation. Funds with higher risk levels may offer better return potential over time, but they can also experience sharper short-term fluctuations. This classification reflects the volatility associated with the fund. Higher risk funds may offer higher returns but come with greater fluctuations.
The asset allocation of Bajaj Healthcare Reg Gr shows how investments are distributed across asset classes.
Equity Allocation: 96.15%
Cash Allocation: 3.68%
This allocation plays a key role in determining the fund’s risk and return profile.
Bajaj Healthcare Reg Gr diversifies its investments across sectors to reduce risk.
Sector Holding Detail
Basic Materials: 4.20%
Consumer Defensive: 2.82%
Financial Services: 1.00%
Healthcare: 87.80%
Industrials: 0.32%
Sector allocation data helps investors understand which industries the fund is focusing on.
Bajaj Healthcare Reg Gr is managed by:
AMC Name: Bajaj Finserv Asset Management Limited
A strong fund house with a proven track record can improve investor confidence.
Investors can start investing in Bajaj Healthcare Reg Gr with:
Minimum Investment: ₹500
This makes the fund accessible for both beginners and experienced investors.
The Bajaj Healthcare Reg Gr has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Divi's Laboratories Ltd | 8.40% |
| Apollo Hospitals Enterprise Ltd | 6.71% |
| Aurobindo Pharma Ltd | 6.52% |
| Sun Pharmaceuticals Industries Ltd | 6.36% |
| Piramal Pharma Ltd | 6.04% |
| Rubicon Research Ltd | 6.02% |
| Torrent Pharmaceuticals Ltd | 5.26% |
| Neuland Laboratories Ltd | 4.59% |
| Emcure Pharmaceuticals Ltd | 4.36% |
| Max Healthcare Institute Ltd Ordinary Shares | 4.16% |
| Fortis Healthcare Ltd | 3.25% |
| Zydus Wellness Ltd | 2.82% |
| Ipca Laboratories Ltd | 2.43% |
| Vijaya Diagnostic Centre Ltd | 2.36% |
| Senores Pharmaceuticals Ltd | 2.29% |
| Navin Fluorine International Ltd | 2.17% |
| Laurus Labs Ltd | 2.14% |
| Shaily Engineering Plastics Ltd | 2.03% |
| Sanofi Consumer Healthcare India Ltd | 1.80% |
| Glenmark Pharmaceuticals Ltd | 1.73% |
| GlaxoSmithKline Pharmaceuticals Ltd | 1.65% |
| Dr. Lal PathLabs Ltd | 1.64% |
| Bajaj Money Market Dir Gr | 1.48% |
| Zydus Lifesciences Ltd | 1.40% |
| Biocon Ltd | 1.35% |
| Abbott India Ltd | 1.25% |
| Medplus Health Services Ltd | 1.18% |
| Krishna Institute of Medical Sciences Ltd | 1.15% |
| Medi Assist Healthcare Services Ltd | 1.04% |
| Eris Lifesciences Ltd Registered Shs | 1.01% |
| Turtlemint Fintech Solutions Ltd | 1.00% |
| Jubilant Pharmova Ltd | 0.96% |
| AstraZeneca Pharma India Ltd | 0.76% |
| MTAR Technologies Ltd | 0.32% |
| Clearing Corporation Of India Ltd | 1.41% |
| Net Receivables / (Payables) | 0.97% |
| ICICI Prudential Life Insurance Co Ltd | - |
The Bajaj Healthcare Reg Gr has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | 4.20% |
| Consumer Defensive | 2.82% |
| Financial Services | 1.00% |
| Healthcare | 87.80% |
| Industrials | 0.32% |
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in Bajaj Healthcare Reg Gr:
By signing up I certify terms, conditions & privacy policy